Rigas, Basil
Renaissance School of Medicine at Stony Brook University,
United States
2025 Rank: 43008
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1845 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43008 | 43129 |
| Total Cites | 8969 | 10204 |
| H-index | 50 | 52 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 231 | 259 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1816 | 1952 |
| Number of Single+First+Last Authored Papers | 166 | 166 |
| Total Cites to Single+First+Last Authored Papers | 7666 | 8774 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6690 | 6936 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.47 |
| Self-Citation Percentage |
12.10%
|
|
Rigas, Basil
Stony Brook University,
United States
2024 Rank: 40842
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1790 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40842 | 40319 |
| Total Cites | 8715 | 9944 |
| H-index | 48 | 51 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 226 | 254 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1773 | 1909 |
| Number of Single+First+Last Authored Papers | 166 | 166 |
| Total Cites to Single+First+Last Authored Papers | 7465 | 8569 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6459 | 6701 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.48 |
| Self-Citation Percentage |
12.36%
|
|
Rigas, Basil
Stony Brook University,
United States
2023 Rank: 38462
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1712 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38462 | 38651 |
| Total Cites | 8476 | 9673 |
| H-index | 47 | 50 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 219 | 247 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1735 | 1870 |
| Number of Single+First+Last Authored Papers | 164 | 164 |
| Total Cites to Single+First+Last Authored Papers | 7279 | 8357 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6245 | 6481 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.49 |
| Self-Citation Percentage |
12.37%
|
|
Rigas, Basil
Renaissance School of Medicine at Stony Brook University,
United States
2022 Rank: 36226
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1632 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36226 | 35657 |
| Total Cites | 8160 | 9329 |
| H-index | 45 | 49 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 216 | 244 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1687 | 1822 |
| Number of Single+First+Last Authored Papers | 161 | 161 |
| Total Cites to Single+First+Last Authored Papers | 7043 | 8100 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5978 | 6207 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.50 |
| Self-Citation Percentage |
12.53%
|
|
Rigas, Basil
Stony Brook University,
United States
2021 Rank: 34488
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1567 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34488 | 34108 |
| Total Cites | 8032 | 9174 |
| H-index | 45 | 48 |
| Hm-index | 22 | 25 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 214 | 242 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 1660 | 1793 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 6885 | 7919 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5834 | 6055 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.52 |
| Self-Citation Percentage |
12.45%
|
|
Rigas, Basil
Stony Brook University,
United States
2020 Rank: 31801
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1518 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31801 | 31498 |
| Total Cites | 7682 | 8807 |
| H-index | 44 | 47 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 207 | 235 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1601 | 1734 |
| Number of Single+First+Last Authored Papers | 155 | 155 |
| Total Cites to Single+First+Last Authored Papers | 6618 | 7638 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5545 | 5761 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.53 |
| Self-Citation Percentage |
12.77%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.